Prescription Required
Zomelis Met 50mg/500mg Tablets are a combination medication that contains Metformin (500mg) and Vildagliptin (50mg), used primarily for the management of type 2 diabetes. This medication helps control blood sugar levels by improving the body's response to insulin and reducing glucose production in the liver. By combining the powerful effects of these two active ingredients, Zomelis Met works efficiently to manage blood glucose levels, thereby reducing the risk of diabetes-related complications.
This tablet is often prescribed when diet, exercise, and other oral diabetes medications alone are not enough to control blood sugar levels. Zomelis Met 50mg/500mg Tablets are an essential part of diabetes treatment for patients who require combined therapy to manage their condition.
It is advisable to limit alcohol consumption while using Zomelis Met. Alcohol may increase the risk of lactic acidosis, a rare but serious condition associated with Metformin.
Zomelis Met should only be used during pregnancy if the benefits outweigh the risks. Always consult with your doctor before taking this medication during pregnancy.
It is unknown whether Zomelis Met passes into breast milk. Consult with your doctor before using this medication while breastfeeding.
Caution is required in patients with kidney problems. Metformin, one of the active ingredients in Zomelis Met, can cause a serious condition called lactic acidosis in people with kidney impairment.
Patients with liver conditions should avoid using Zomelis Met. Always discuss with your healthcare provider if you have liver problems before using this medication.
Zomelis Met is not known to impair your ability to drive. However, if you experience dizziness or fatigue, avoid driving or operating heavy machinery.
Zomelis Met combines Metformin (500mg) and Vildagliptin (50mg) to effectively manage type 2 diabetes. Metformin, a biguanide, reduces glucose production in the liver and enhances insulin sensitivity in muscles, helping to lower blood sugar levels without increasing the risk of hypoglycemia. Vildagliptin, a DPP-4 inhibitor, boosts insulin production when blood glucose levels are high and reduces glucose release from the liver for better control. Together, these ingredients work synergistically to maintain stable blood sugar levels, making Zomelis Met a potent treatment for type 2 diabetes.
Diabetes Mellitus type 2 - Either the body stops producing enough insulin, or there is resistance to insulin action.
Store Zomelis Met at room temperature, in a dry place away from moisture and heat. Do not store it in the bathroom, and keep it out of reach of children.
Zomelis Met 50mg/500mg Tablets combine Metformin and Vildagliptin to manage blood sugar levels in patients with type 2 diabetes. This dual-action medication offers effective control of glucose levels, with fewer risks of hypoglycemia and complications. Always consult your healthcare provider before starting treatment, and follow the prescribed dosage and lifestyle recommendations for optimal results.
Content Updated on
Wednesday, 19 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA